Question: Ms. Harris is a 53 y/o female with a past medical history of a myocardial infarction with a stent placement and stage III heart failure. She was recently diagnosed with type 2 DM and started on metformin. During a follow up appointment, her Hgb A1c is still not at target despite maximum dosing of metformin. The NP is considering adding a second agent. Which would be the preferred second agent for this patient? a. Dapagliflozin b. Miglitol c. Sitagliptin d. Liraglutide